SFMBT1 functions with LSD1 to regulate expression of canonical histone genes and chromatin-related factors

Genes and Development

Volumn 27, Issue 7, 2013, Pages 749-766

  Zhang, Jin ^a   Bonasio, Roberto ^a   Strino, Francesco ^b   Kluger, Yuval ^b   Holloway, J Kim ^c   Modzelewski, Andrew J ^c   Cohen, Paula E ^c   Reinberg, Danny ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

^c Department of Obstetrics Gynecology   (United States)

Author keywords

LSD1; Polycomb; SFMBT

Indexed keywords

COREST PROTEIN; HISTONE; LSD1 PROTEIN; PROTEIN; RNA POLYMERASE II; SFMBT1 PROTEIN; SFMBT2 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CHROMATIN; COMPLEX FORMATION; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE LOCUS; GENE LOSS; GENE REPLICATION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; GERM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SOMATIC CELL; SPERMATID; SPERMATOCYTE; SPERMATOGENESIS; SYNAPSE; TRANSCRIPTION REGULATION;

ANIMALS; CHROMATIN; GENE EXPRESSION REGULATION; GENOME; HEK293 CELLS; HELA CELLS; HISTONE DEMETHYLASES; HISTONES; HUMANS; MALE; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; OXIDOREDUCTASES, N-DEMETHYLATING; PROTEIN BINDING; PROTEIN STABILITY; PROTEIN TRANSPORT; REPRESSOR PROTEINS; SF9 CELLS; SPERMATOGENESIS; TESTIS;

MAMMALIA;

EID: 84876255033     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.210963.112     Document Type: Article

References (67)

1. Asp P, Blum R, Vethantham V, Parisi F, Micsinai M, Cheng J, Bowman C, Kluger Y, Dynlacht BD. 2011. Genome-wide remodeling of the epigenetic landscape during myogenic differentiation. Proc Natl Acad Sci 108: E149-E158.
2. Ballas N, Battaglioli E, Atouf F, Andres ME, Chenoweth J, Anderson ME, Burger C, Moniwa M, Davie JR, Bowers WJ, et al. 2001. Regulation of neuronal traits by a novel transcriptional complex. Neuron 31: 353-365.
3. Banaszynski LA, Allis CD, Lewis PW. 2010. Histone variants in metazoan development. Dev Cell 19: 662-674.
4. Beisel C, Paro R. 2011. Silencing chromatin: Comparing modes and mechanisms. Nat Rev Genet 12: 123-135.
5. Berger SL. 2007. The complex language of chromatin regulation during transcription. Nature 447: 407-412.
6. Bonasio R, Lecona E, Reinberg D. 2010. MBT domain proteins in development and disease. Semin Cell Dev Biol 21: 221-230.
7. Cai Y, Jin J, Yao T, Gottschalk AJ, Swanson SK, Wu S, Shi Y, Washburn MP, Florens L, Conaway RC, et al. 2007. YY1 functions with INO80 to activate transcription. Nat Struct Mol Biol 14: 872-874.
8. Campos EI, Reinberg D. 2009. Histones: Annotating chromatin. Annu Rev Genet 43: 559-599.
9. Christensen KL, Patrick AN, McCoy EL, Ford HL. 2008. The six family of homeobox genes in development and cancer. Adv Cancer Res 101: 93-126.
10. Cohen PE, Pollard JW. 2001. Regulation of meiotic recombination and prophase I progression in mammals. Bioessays 23: 996-1009.
11. Cohen PE, Pollack SE, Pollard JW. 2006. Genetic analysis of chromosome pairing, recombination, and cell cycle control during first meiotic prophase in mammals. Endocr Rev 27: 398-426.
12. Gao Z, Zhang J, Bonasio R, Strino F, Sawai A, Parisi F, Kluger Y, Reinberg D. 2012. PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. Mol Cell 45: 344-356.
13. Garcia-Bassets I, Kwon YS, Telese F, Prefontaine GG, Hutt KR, Cheng CS, Ju BG, Ohgi KA, Wang J, Escoubet-Lozach L, et al. 2007. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 128: 505-518.
14. Godmann M, Auger V, Ferraroni-Aguiar V, Di Sauro A, Sette C, Behr R, Kimmins S. 2007. Dynamic regulation of histone H3 methylation at lysine 4 in mammalian spermatogenesis. Biol Reprod 77: 754-764.
15. Hakimi MA, Bochar DA, Chenoweth J, Lane WS, Mandel G, Shiekhattar R. 2002. A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes. Proc Natl Acad Sci 99: 7420-7425.
16. Harrison MM, Lu X, Horvitz HR. 2007. LIN-61, one of two Caenorhabditis elegans malignant-brain-tumor-repeat-con- taining proteins, acts with the DRM and NuRD-like protein complexes in vulval development but not in certain other biological processes. Genetics 176: 255-271.
17. Holloway JK, Booth J, Edelmann W, McGowan CH, Cohen PE. 2008. MUS81 generates a subset of MLH1-MLH3-independent crossovers in mammalian meiosis. PLoS Genet 4: e1000186.
18. Huang DW, Sherman BT, Lempicki RA. 2009a. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.
19. Huang DW, Sherman BT, Lempicki RA. 2009b. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
20. Humphrey GW, Wang Y, Russanova VR, Hirai T, Qin J, Nakatani Y, Howard BH. 2001. Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1. J Biol Chem 276: 6817-6824.
21. Janic A, Mendizabal L, Llamazares S, Rossell D, Gonzalez C. 2010. Ectopic expression of germline genes drives malignant brain tumor growth in Drosophila. Science 330: 1824-1827.
22. Kalakonda N, Fischle W, Boccuni P, Gurvich N, Hoya-Arias R, Zhao X, Miyata Y, Macgrogan D, Zhang J, Sims JK, et al. 2008. Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1. Oncogene 27: 4293-4304.
23. Katz DJ, Edwards TM, Reinke V, Kelly WG. 2009. A C. elegans LSD1 demethylase contributes to germline immortality by reprogramming epigenetic memory. Cell 137: 308-320.
24. Kim CA, Sawaya MR, Cascio D, Kim W, Bowie JU. 2005. Structural organization of a Sex-comb-on-midleg/polyhomeotic copolymer. J Biol Chem 280: 27769-27775.
25. Kimmins S, Sassone-Corsi P. 2005. Chromatin remodelling and epigenetic features of germ cells. Nature 434: 583-589.
26. Klymenko T, Papp B, Fischle W, Kocher T, Schelder M, Fritsch C, Wild B, Wilm M, Muller J. 2006. A Polycomb group protein complex with sequence-specific DNA-binding and selective methyl-lysine-binding activities. Genes Dev 20: 1110-1122.
27. Kouzarides T. 2007. Chromatin modifications and their function. Cell 128: 693-705.
28. Kuzmichev A, Jenuwein T, Tempst P, Reinberg D. 2004. Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol Cell 14: 183-193.
29. Kuzmin A, Han Z, Golding MC, Mann MR, Latham KE, Varmuza S. 2008. The PcG gene Sfmbt2 is paternally expressed in extraembryonic tissues. Gene Expr Patterns 8: 107-116.
30. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
31. Li G, Reinberg D. 2011. Chromatin higher-order structures and gene regulation. Curr Opin Genet Dev 21: 175-186.
32. Li B, Carey M, Workman JL. 2007. The role of chromatin during transcription. Cell 128: 707-719.
33. Li H, Fischle W, Wang W, Duncan EM, Liang L, Murakami- Ishibe S, Allis CD, Patel DJ. 2007. Structural basis for lower lysine methylation state-specific readout by MBT repeats of L3MBTL1 and an engineered PHD finger. Mol Cell 28: 677-691.
34. Lu J, Ruhf ML, Perrimon N, Leder P. 2007. A genome-wide RNA interference screen identifies putative chromatin regulators essential for E2F repression. Proc Natl Acad Sci 104: 9381-9386.
35. Marzluff WF, Gongidi P, Woods KR, Jin J, Maltais LJ. 2002. The human and mouse replication-dependent histone genes. Genomics 80: 487-498.
36. Marzluff WF, Wagner EJ, Duronio RJ. 2008. Metabolism and regulation of canonical histone mRNAs: Life without a poly(A) tail. Nat Rev Genet 9: 843-854.
37. Maurer-Stroh S, Dickens NJ, Hughes-Davies L, Kouzarides T, Eisenhaber F, Ponting CP. 2003. The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains. Trends Biochem Sci 28: 69-74.
38. McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, Wenger AM, Bejerano G. 2010. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 28: 495-501.
39. Meier K, Mathieu EL, Finkernagel F, Reuter LM, Scharfe M, Doehlemann G, Jarek M, Brehm A. 2012. LINT, a novel dL(3)mbt-containing complex, represses malignant brain tumour signature genes. PLoS Genet 8: e1002676.
40. Micsinai M, Parisi F, Strino F, Asp P, Dynlacht BD, Kluger Y. 2012. Picking ChIP-seq peak detectors for analyzing chromatin modification experiments. Nucleic Acids Res 40: e70.
41. Min J, Allali-Hassani A, Nady N, Qi C, Ouyang H, Liu Y, MacKenzie F, Vedadi M, Arrowsmith CH. 2007. L3MBTL1 recognition of mono- and dimethylated histones. Nat Struct Mol Biol 14: 1229-1230.
42. Muller J, Kassis JA. 2006. Polycomb response elements and targeting of Polycomb group proteins in Drosophila. Curr Opin Genet Dev 16: 476-484.
43. Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y. 2002. A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science 296: 1132-1136.
44. Osley MA. 1991. The regulation of histone synthesis in the cell cycle. Annu Rev Biochem 60: 827-861.
45. Parkhomchuk D, Borodina T, Amstislavskiy V, Banaru M, Hallen L, Krobitsch S, Lehrach H, Soldatov A. 2009. Transcriptome analysis by strand-specific sequencing of complementary DNA. Nucleic Acids Res 37: e123.
46. Peterson AJ, Kyba M, Bornemann D, Morgan K, Brock HW, Simon J. 1997. A domain shared by the Polycomb group proteins Scm and ph mediates heterotypic and homotypic interactions. Mol Cell Biol 17: 6683-6692.
47. Ruthenburg AJ, Li H, Patel DJ, Allis CD. 2007. Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol 8: 983-994.
48. Sarma K, Reinberg D. 2005. Histone variants meet their match. Nat Rev Mol Cell Biol 6: 139-149.
49. Sathyamurthy A, Allen MD, Murzin AG, Bycroft M. 2003. Crystal structure of the malignant brain tumor (MBT) repeats in Sex Comb on Midleg-like 2 (SCML2). J Biol Chem 278: 46968-46973.
50. Schwartz YB, Pirrotta V. 2008. Polycomb complexes and epigenetic states. Curr Opin Cell Biol 20: 266-273.
51. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA. 2004. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119: 941-953.
52. Simon JA, Kingston RE. 2009. Mechanisms of polycomb gene silencing: Knowns and unknowns. Nat Rev Mol Cell Biol 10: 697-708.
53. Spitz F, Furlong EE. 2012. Transcription factors: From enhancer binding to developmental control. Nat Rev Genet 13: 613-626.
54. Stein GS, van Wijnen AJ, Stein JL, Lian JB, Montecino M, Zaidi SK, Braastad C. 2006. An architectural perspective of cellcycle control at the G1/S phase cell-cycle transition. J Cell Physiol 209: 706-710.
55. Takada Y, Isono K, Shinga J, Turner JM, Kitamura H, Ohara O, Watanabe G, Singh PB, Kamijo T, Jenuwein T, et al. 2007. Mammalian Polycomb Scmh1 mediates exclusion of Polycomb complexes from the XY body in the pachytene spermatocytes. Development 134: 579-590.
56. Takahashi Y, Rayman JB, Dynlacht BD. 2000. Analysis of promoter binding by the E2F and pRB families in vivo: Distinct E2F proteins mediate activation and repression. Genes Dev 14: 804-816.
57. Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ. 2007. How chromatin-binding modules interpret histone modifications: Lessons from professional pocket pickers. Nat Struct Mol Biol 14: 1025-1040.
58. Trojer P, Li G, Sims RJ III, Vaquero A, Kalakonda N, Boccuni P, Lee D, Erdjument-Bromage H, Tempst P, Nimer SD, et al. 2007. L3MBTL1, a histone-methylation-dependent chromatin lock. Cell 129: 915-928.
59. Trojer P, Cao AR, Gao Z, Li Y, Zhang J, Xu X, Li G, Losson R, Erdjument-Bromage H, Tempst P, et al. 2011. L3MBTL2 protein acts in concert with PcG protein-mediated monoubiquitination of H2A to establish a repressive chromatin structure. Mol Cell 42: 438-450.
60. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E, Chang HY. 2010. Long noncoding RNA as modular scaffold of histone modification complexes. Science 329: 689-693.
61. Vaquero A, Scher M, Lee D, Erdjument-Bromage H, Tempst P, Reinberg D. 2004. Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell 16: 93-105.
62. Wang KC, Chang HY. 2011. Molecular mechanisms of long noncoding RNAs. Mol Cell 43: 904-914.
63. Wang WK, Tereshko V, Boccuni P, MacGrogan D, Nimer SD, Patel DJ. 2003. Malignant brain tumor repeats: A threeleaved propeller architecture with ligand/peptide binding pockets. Structure 11: 775-789.
64. Whyte WA, Bilodeau S, Orlando DA, Hoke HA, Frampton GM, Foster CT, Cowley SM, Young RA. 2012. Enhancer decommissioning by LSD1 during embryonic stem cell differentiation. Nature 482: 221-225.
65. Wu S, Shi Y, Mulligan P, Gay F, Landry J, Liu H, Lu J, Qi HH, Wang W, Nickoloff JA, et al. 2007a. A YY1-INO80 complex regulates genomic stability through homologous recombination- based repair. Nat Struct Mol Biol 14: 1165-1172.
66. Wu S, Trievel RC, Rice JC. 2007b. Human SFMBT is a transcriptional repressor protein that selectively binds the N-terminal tail of histone H3. FEBS Lett 581: 3289-3296.
67. You A, Tong JK, Grozinger CM, Schreiber SL. 2001. CoREST is an integral component of the CoREST-human histone deacetylase complex. Proc Natl Acad Sci 98: 1454-1458.